- Trials with a EudraCT protocol (51)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (14)
51 result(s) found for: Emergency medicine.
Displaying page 1 of 3.
EudraCT Number: 2016-003773-17 | Sponsor Protocol Number: dex_version1 | Start Date*: 2017-06-12 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: A prospective randomized open label study Intranasal dexmedetomidine versus inhaled nitrous oxide for children age 3 – 15 years for procedural sedation and analgesia in pediatric emergency departme... | ||
Medical condition: sedation for emergency procedures | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2017-000057-40 | Sponsor Protocol Number: dex_vs_ket | Start Date*: 2017-06-12 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: A prospective randomized double-blind study Intranasal dexmedetomidine versus intranasal S-ketamine for children age 1 – 3 years for procedural sedation and analgesia in pediatric emergency departm... | ||
Medical condition: sedation for emergency procedures | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-002498-80 | Sponsor Protocol Number: 06062019 | Start Date*: 2019-09-24 | |||||||||||
Sponsor Name:Mikkel Brabrand | |||||||||||||
Full Title: Will titrated oxygen flow to a peripheral oxygen saturation of 88-92% compared with oxygen flow to a saturation >94% reduce mortality in Chronic Obstructive Pulmonary Disease patients with acute ex... | |||||||||||||
Medical condition: Acute COPD Exacerbation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000695-34 | Sponsor Protocol Number: Verna-Ibu-AF_1.0 | Start Date*: 2011-07-22 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Univ.-Klinik für Notfallmedizin | |||||||||||||
Full Title: Vernakalant Versus Ibutilide In Recent-Onset Atrial Fibrillation | |||||||||||||
Medical condition: recent-onset atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000452-28 | Sponsor Protocol Number: VIPER-OCTA | Start Date*: 2014-11-05 | |||||||||||
Sponsor Name:Section for Transfusion Medicine, Capitol Region Blood Bank | |||||||||||||
Full Title: Vasculopathic Injury and Plasma as Endothelial Rescue – OCTAplas trial | |||||||||||||
Medical condition: patients undergoing emergency surgery for thoracic aortic dissections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003387-46 | Sponsor Protocol Number: COCA2 | Start Date*: 2019-10-28 | |||||||||||
Sponsor Name:Research Center for Emergency Medicine Department of Clinical Medicine Aarhus University | |||||||||||||
Full Title: Calcium for Out-of-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled trial | |||||||||||||
Medical condition: The study will include patients with out-of-hospital cardiac arrest (OHCA). The study will test whether treatment with Calcium Chloride added to standard care will improve survival following OHCA. ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004082-41 | Sponsor Protocol Number: DELIcu | Start Date*: 2013-03-06 | |||||||||||
Sponsor Name:Dekan of Faculty of Medicine of Goethe-University Frankfurt | |||||||||||||
Full Title: Monocenter, double blind, randomised, placebo controlled study t evaluate Physostigmin for the Treatment of delirium in perioperative intensive care medicine | |||||||||||||
Medical condition: patients with delirium in perioperative intensive care medicine | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004773-13 | Sponsor Protocol Number: 00001 | Start Date*: 2018-02-27 | |||||||||||
Sponsor Name:Research Center for Emergency Medicine Department of Clinical Medicine Aarhus University | |||||||||||||
Full Title: Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest – A Randomized, Double-Blind, Placebo-Controlled Trial | |||||||||||||
Medical condition: The study will include patients with in-hospital cardiac arrest (IHCA). The study will test whether treatment with methylprednisolone and vasopressin added to standard care will improve survival fo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000224-35 | Sponsor Protocol Number: RECEM00001 | Start Date*: 2021-07-28 | |||||||||||
Sponsor Name:Marie Kristine Jessen | |||||||||||||
Full Title: Restrictive Fluid Administration vs. Standard of Care in Emergency Department Sepsis Patients - a Multicenter, Randomized Clinical Feasibility Trial | |||||||||||||
Medical condition: Sepsis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000338-12 | Sponsor Protocol Number: MEOF-001 | Start Date*: 2011-06-28 | |||||||||||
Sponsor Name:Medical Developments International Limited | |||||||||||||
Full Title: A randomised, double blind, multi-centre, placebo controlled study to evaluate the efficacy and safety of methoxyflurane (Penthrox(TM)) for the treatment of acute pain in patients presenting to an ... | |||||||||||||
Medical condition: Acute pain | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004961-25 | Sponsor Protocol Number: 2008/0827 | Start Date*: 2008-12-03 |
Sponsor Name:CHRU de Lille | ||
Full Title: ETUDE COMPARATIVE KETAMINE DOSE UNIQUE VERSUS KETAMINE BOLUS ET PERFUSION CONTINUE DANS LA PRISE EN CHARGE DE L’ANALGESIE DES DOULEURS TRAUMATIQUES DES MEMBRES EN MEDECINE D’URGENCE PREHOSPITALIERE | ||
Medical condition: Limbs peripheral traumatisms in prehospital emergency medicine | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000898-23 | Sponsor Protocol Number: 2019/KEP/218 | Start Date*: 2019-08-01 | |||||||||||
Sponsor Name:London School of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Pharmacokinetics of intramuscular tranexamic acid in trauma patients: a clinical trial | |||||||||||||
Medical condition: Traumatic haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000307-32 | Sponsor Protocol Number: Repha_1439 | Start Date*: 2020-05-12 | |||||||||||
Sponsor Name:Repha GmbH | |||||||||||||
Full Title: Clinical trial for examination of efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhea-dominant irritable bowel syndrom (IBS-D) | |||||||||||||
Medical condition: Confirmed diagnosis of diarrhea-dominant irritable bowel syndrome (IBS-D) by a specialist physician and/or internal medicine and/or general medicine | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004762-15 | Sponsor Protocol Number: VUMC38027 | Start Date*: 2012-08-22 |
Sponsor Name:VU Univeristy Medical Centre | ||
Full Title: Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON study | ||
Medical condition: Delirium | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001198-55 | Sponsor Protocol Number: KronLungesyg_COVID_19_protokol_2 | Start Date*: 2020-04-03 | ||||||||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | ||||||||||||||||||
Full Title: Proactive Prophylaxis with Azithromycin and Hydroxychloroquine Patients Hospitalized with COVID | ||||||||||||||||||
Medical condition: This trial will investigate infection with coronavirus (COVID-19) in patients who are admitted to hospital | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000338-70 | Sponsor Protocol Number: MR311-3502 | Start Date*: 2017-06-19 | ||||||||||||||||
Sponsor Name:Mundipharma Pharmaceuticals, S.L. | ||||||||||||||||||
Full Title: A phase IIIb open randomized clinical trial to compare pain relief between methoxyflurane and standard of care for treating patients with trauma pain in Spanish emergency units. | ||||||||||||||||||
Medical condition: Trauma Pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003391-40 | Sponsor Protocol Number: 2020-KEP-456 | Start Date*: 2020-12-17 | |||||||||||
Sponsor Name:London School of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Intramuscular tranexamic acid for the treatment of symptomatic mild traumatic brain injury in older adults: a randomised, double-blind, placebo-controlled trial. | |||||||||||||
Medical condition: Mild traumatic brain injury. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003669-14 | Sponsor Protocol Number: ISRCTN15088122 | Start Date*: 2012-12-03 | |||||||||||
Sponsor Name:London School Of Hygiene and Tropical Medicine | |||||||||||||
Full Title: Tranexamic Acid for the treatment of significant traumatic brain injury: an international, randomised, double blind, placebo controlled trial. | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) IT (Completed) IE (Completed) SI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000632-34 | Sponsor Protocol Number: AAUH-ICU-01 | Start Date*: 2017-04-25 | ||||||||||||||||
Sponsor Name:Department of Anaesthesia and Intensive Care Medicine, Aalborg University Hospital | ||||||||||||||||||
Full Title: Handling oxygenation targets in adults with acute hypoxaemic respiratory failure in the intensive care unit: A randomised clinical trial of a lower versus a higher oxygenation target Addendum: Tri... | ||||||||||||||||||
Medical condition: Acute hypoxaemic respiratory failure in patients admitted to the intensive care unit Addendum: Acute hypoxaemic respiratory failure in patients admitted to the intensive care unit with COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005216-28 | Sponsor Protocol Number: VNK115640 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:GlaxoSmithKline | |||||||||||||
Full Title: A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 3... | |||||||||||||
Medical condition: Post-operative nausea and vomiting (PONV) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
